Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Administrative data

Description of key information

Key value for chemical safety assessment

Skin sensitisation

Endpoint conclusion
Endpoint conclusion:
no adverse effect observed (not sensitising)
Additional information:

Diethanolamine, propoxylated was tested in the modified Local Lymph Node Assay (IMDS) in female NMRI mice using dermal application of up to and including a 50% concentration. The "positive level" of ear swelling which is 2 x 10-2 mm increase, i.e. about 10% of the control values, has not been reached or exceeded in any dose group. Nevertheless a statistically significant increase has been detected after administration of the high concentration of the test item in ear weights. Although this effect is not corroborated by increase in ear swelling an irritant potential can not be excluded.

It has to be clarified that the "positive levels" mentioned above are exclusively defined for the NMRI outbred mice used for this study. Such positive limits have to be calculated for each strain of mice individually.

The body weights of the animals were not affected by any treatment. Based on these results, classification of Diethanolamine, propoxylated as skin sensitiser is not warranted.


Migrated from Short description of key information:
Not a sensitiser in a modified Local Lymph Node Assay.

Respiratory sensitisation

Endpoint conclusion
Endpoint conclusion:
no adverse effect observed (not sensitising)

Justification for classification or non-classification

The LLNA result indicates that the substance does not meet the criterion for classification as a skin sensitiser.